Cardinal Reports an In-Line Quarter as Its Core Drug Wholesaling Business Stabilizes
Near-term issues plagued Cardinal’s core pharmaceutical distribution segment during its fiscal first quarter; however, these issues seem to have abated during its second-quarter, as the firm was able to leverage its generic sourcing partnership with CVS and lower its generic drug costs. However, the firm did face some issues within its medical product business, as pricing pressure and inefficiencies within the Cordis operations pressured profits. While the firm’s results for the quarter were not...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.